Meredith Gray, MD
Obstetrics & Gynecology · Kansas City, KSNPI 1740504414
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Applied Medical Resources Corporation accounts for 90.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $3,030 and has fallen 98.6% since, to $43 in 2025. Among obstetrics & gynecology clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $208.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$5K
- Olympus America Inc.$221
- Antares Pharma, Inc.$72
- Minerva Surgical, Inc$42
- AbbVie$34
- Halozyme Inc$33
- plus $154 from 8 others
What the payments were for
- Speaking & faculty fees$3,00053%
- Travel & lodging$1,87433%
- Food & beverage$75213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$4,874
- Olympus$221
How this compares
$5,626 in reported general payments places this provider in the 90th percentile of 302 obstetrics & gynecology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 77 | $3,817 |
| Estradiol Valerate | 20 | $2,459 |
| Estradiol (Twice Weekly)Estradiol | 18 | $1,546 |
| Testosterone Cypionate | 36 | $1,111 |
| ProgesteroneProgesterone, Micronized | 17 | $1,051 |
| Spironolactone | 18 | $402 |
| Medroxyprogesterone Acetate | 12 | $256 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kansas City
- Austin FindleyKansas City$18K
- Madhuri ReddyKansas City$13K
- Melanie MeisterKansas City$6K
- Erin CareyKansas City$6K
- Linden CollinsKansas City$4K
- Sherebanu GaslightwalaKansas City$3K
- Kristi Weaver RoweKansas City$3K
- Kimberly SwanOverland Park$123K
- Michael FenechPittsburg$65K
- Michael MageeShawnee Mission$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.